Literature DB >> 12658197

Major bleeding complicating deep sternal infection after cardiac surgery.

Alon Yellin1, Yael Refaely, Michael Paley, David Simansky.   

Abstract

OBJECTIVES: This study was undertaken to determine the incidence and outcome of major bleeding complicating deep sternal infection after cardiac surgery, to identify predisposing factors and means of prevention, and to clarify management options.
METHODS: This was a retrospective study of 10,863 consecutive patients, of whom 213 (2.18%) acquired deep sternal infection. With 43 additional referrals, the total number of patients with deep sternal infection was 280. Deep sternal infection was managed by a two-stage scheme. Major bleeding was considered to be bleeding that occurred during or after operation for deep sternal infection from the heart, great vessels, or grafts, or bleeding requiring urgent exploration.
RESULTS: Fifteen patients (5.36%) had major bleeding. The incidences of deep sternal infection and bleeding were highest among patients undergoing coronary artery bypass grafting. Thirteen patients had underlying diseases (type 2 diabetes in 9 cases). Deep sternal infection was diagnosed a median of 15 days after reoperation. Bleeding originated from the right ventricle in 9 patients. In 4 patients bleeding was iatrogenic during surgery for wire removal (n = 2) or reconstruction (n = 2). In 11 it occurred 15 minutes to 15 days (median 2 days) after wire removal, as a result of shearing forces in 7 cases and of infection only in 4 cases. Three patients died immediately. The other 12 were operated on, 6 with complete cardiopulmonary bypass, 2 with femoral cannulation, and 4 without cardiopulmonary bypass. The immediate mortality was 26.7%; the overall mortality was 53.3%. The median length of hospitalization of surviving patients was 38 days.
CONCLUSIONS: The probability of development of major bleeding in patients with deep sternal infection was unrelated to the primary operation. The mortality associated with this complication was high. Meticulous technique during wire removal may decrease the risk of major bleeding. The impacts of cardiopulmonary bypass and of the technique and timing of sternal reconstruction remain undetermined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12658197     DOI: 10.1067/mtc.2003.31

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

Review 1.  Major bleeding during negative pressure wound/V.A.C.®--therapy for postsurgical deep sternal wound infection--a critical appraisal.

Authors:  Jan J van Wingerden; Patrique Segers; Lilian Jekel
Journal:  J Cardiothorac Surg       Date:  2011-09-29       Impact factor: 1.637

2.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Major cardiac rupture following surgical treatment for deep sternal wound infection.

Authors:  David T Thorsteinsson; Felix Valsson; Arnar Geirsson; Tomas Gudbjartsson
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-27

4.  Revascularization for patients with idiopathic thrombocytopenic purpura and coronary artery disease.

Authors:  Chan-Hee Lee; Ung Kim
Journal:  Korean Circ J       Date:  2014-07-25       Impact factor: 3.243

5.  Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literature.

Authors:  Matthew W Reynolds; John Clark; Sheila Crean; Srinath Samudrala
Journal:  Patient Saf Surg       Date:  2008-03-18

6.  Post-trauma "abrasive" right ventricular rupture without mediastinitis early post-CABG. Is the Robicsek closure technique necessary for all elderly patients?

Authors:  Haris Georgiou; Vasileios Patris; Niki Lama; Orestis Argiriou; Kostas Soultanis
Journal:  Int J Surg Case Rep       Date:  2014-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.